DeCode 2000 Revenues Jump 30 Percent to $21.5M | GenomeWeb

NEW YORK, March 15 – DeCode Genetics said Thursday its full-year 2000 revenue rose 30 percent to $21.5 million, compared with $16.6 million in 1999, due primarily to higher milestone payments stemming from the company’s research collaboration with Roche.

Of the $21.5 million, $10.1 million in revenues was recorded in the fourth quarter. However, DeCode did not report other figures on a quarterly basis.

For the year, DeCode recorded a 47 percent increase in total operating expenses to $61.1 million, as research and development and general and administrative costs rose.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.